298 related articles for article (PubMed ID: 33468749)
1. [A Case of Locally Advanced Rectal Cancer Treated by Robot Assisted Intersphincteric Resection after Neoadjuvant Chemotherapy].
Kusafuka H; Kagawa Y; Kawai K; Hata T; Imada A; Sakamoto T; Murakami K; Katsura Y; Omura Y; Masuzawa T; Takeno A; Takeda Y; Murata K
Gan To Kagaku Ryoho; 2021 Jan; 48(1):145-147. PubMed ID: 33468749
[TBL] [Abstract][Full Text] [Related]
2. [A Resected Case of Advanced Lower Rectal Cancer with Neoadjuvant Chemotherapy by FOLFOXIRI plus Cetuximab].
Yamada K; Ioka T; Suzuki N; Yoshida S; Tomochika S; Matsukuma S; Matsui H; Shindo Y; Tokumitsu Y; Watanabe Y; Iida M; Takeda S; Hazama S; Ueno T; Nagano H
Gan To Kagaku Ryoho; 2021 Dec; 48(13):2067-2069. PubMed ID: 35045495
[TBL] [Abstract][Full Text] [Related]
3. [A Case of Pathological CR in Local Advanced Rectal Cancer Treated with Laparoscopic ISR after XELOXIRI Chemotherapy].
Kawai K; Murata K; Hata T; Kagawa Y; Naito A; Sakamoto T; Murakami K; Katsura Y; Omura Y; Masuzawa T; Takeno A; Takeda Y
Gan To Kagaku Ryoho; 2019 Dec; 46(13):2096-2097. PubMed ID: 32157071
[TBL] [Abstract][Full Text] [Related]
4. [A Long-Survival Case of Lower Rectal Cancer with Unresectable Liver Metastases Treated with FOLFOXIRI plus Bevacizumab(BEV)].
Kagawa Y; Inoue A; Nishizawa Y; Kawai K; Ohta T; Hata T; Naito A; Komatsu H; Miyazaki Y; Tomokuni A; Motoori M; Fujitani K; Kato T; Takeda Y; Murata K
Gan To Kagaku Ryoho; 2021 Dec; 48(13):1819-1821. PubMed ID: 35046341
[TBL] [Abstract][Full Text] [Related]
5. [A case of rectal endocrine cell carcinoma treated by laparoscopic assisted intersphincteric resection after neoadjuvant chemotherapy].
Wakatsuki K; Yoshioka S; Shiobara M; Kataoka M; Arai S; Tonooka T; Miyazawa K; Oeda Y
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2026-8. PubMed ID: 24394001
[TBL] [Abstract][Full Text] [Related]
6. Intensified Total Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer: A Phase II Trial.
De Felice F; D'Ambrosio G; Iafrate F; Gelibter A; Magliocca FM; Musio D; Caponetto S; Casella G; Clementi I; Picchetto A; Sirgiovani G; Parisi M; Orciuoli C; Torrese G; De Toma G; Tombolini V; Cortesi E
Clin Oncol (R Coll Radiol); 2021 Dec; 33(12):788-794. PubMed ID: 34176711
[TBL] [Abstract][Full Text] [Related]
7. [A Case of Pathological Complete Response with Neoadjuvant Chemotherapy for Advanced Rectal Cancer].
Okada S; Kameyama H; Abe K; Tanaka K; Oyanagi H; Nakano M; Ichikawa H; Hanyu T; Takizawa K; Nakano M; Nagahashi M; Shimada Y; Sakata J; Kobayashi T; Wakai T
Gan To Kagaku Ryoho; 2019 Dec; 46(13):2057-2059. PubMed ID: 32157058
[TBL] [Abstract][Full Text] [Related]
8. [A case of pathological complete response with neoadjuvant mFOLFOX6 chemotherapy for advanced lower rectal cancer].
Sueda T; Noura S; Ohue M; Shingai T; Gotoh K; Motoori M; Takahashi H; Kishi K; Marubashi S; Fujiwara Y; Ohigashi H; Yano M; Tomita Y; Ishikawa O
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1965-7. PubMed ID: 24393981
[TBL] [Abstract][Full Text] [Related]
9. [A Case of a Patient with Locally Recurrent Rectal Cancer Who Underwent Surgical Resection after Chemotherapy with FOLFOXIRI plus Bevacizumab].
Shigoka M; Enomoto M; Wada T; Mazaki J; Kuwabara H; Ishizaki T; Ishibashi Y; Nagakawa Y; Katsumata K; Tsuchida A
Gan To Kagaku Ryoho; 2019 Apr; 46(4):796-798. PubMed ID: 31164539
[TBL] [Abstract][Full Text] [Related]
10. [A Case of Laparoscopic Surgery for Advanced Rectal Cancer with Lateral Lymph Node Metastasis Resected after Neoadjuvant Chemotherapy].
Motoki Y; Sugimoto K; Sakisaka H; Nakano K; Kan K; Nakaguchi K; Doi S
Gan To Kagaku Ryoho; 2018 Dec; 45(13):2357-2359. PubMed ID: 30692463
[TBL] [Abstract][Full Text] [Related]
11. [Two Cases of Metastatic Rectal Cancer Patients Who Received Chemotherapy with FOLFOXIRI plus Bevacizumab].
Nishii T; Uchima Y; Yamakoshi Y; Wang E; Nagashima D; Hirakawa T; Aomatsu N; Iwauchi T; Morimoto J; Nakazawa K; Tei S; Takeuchi K
Gan To Kagaku Ryoho; 2016 Nov; 43(12):1705-1707. PubMed ID: 28133105
[TBL] [Abstract][Full Text] [Related]
12. [Two Cases of Unresectable Advanced Rectal Cancer with a Long-Term Survival for Which Pathological Complete Response Was Achieved through Neoadjuvant Effective Chemotherapy].
Gonda K; Tachiya Y; Hatakeyama Y; Shibata M; Kono K; Rokkaku Y
Gan To Kagaku Ryoho; 2017 Oct; 44(10):944-946. PubMed ID: 29066704
[TBL] [Abstract][Full Text] [Related]
13. [A case of neoadjuvant chemotherapy for locally advanced rectal cancer, which had a invasion into the vagina followed by curative resection].
Kimura K; Kagawa Y; Kato T; Ishida T; Morimoto Y; Matusita K; Kusama H; Hashimoto T; Katura Y; Nitta K; Takeno A; Nakahira S; Okishiro M; Sakisaka H; Taniguchi H; Egawa C; Takeda Y; Tamura S
Gan To Kagaku Ryoho; 2014 Nov; 41(12):1740-2. PubMed ID: 25731314
[TBL] [Abstract][Full Text] [Related]
14. Total neoadjuvant approach with FOLFOXIRI plus bevacizumab followed by chemoradiotherapy plus bevacizumab in locally advanced rectal cancer: the TRUST trial.
Masi G; Vivaldi C; Fornaro L; Lonardi S; Buccianti P; Sainato A; Marcucci L; Martignetti A; Luca Urso ED; Castagna M; Fontanini G; Bergamo F; Musettini G; Urbani L; Sensi E; Balestri R; Montrone S; Pasqualetti F; Cremolini C; Di Paolo A; Zagonel V; Falcone A
Eur J Cancer; 2019 Mar; 110():32-41. PubMed ID: 30739838
[TBL] [Abstract][Full Text] [Related]
15. Laparoscopic abdominosacral resection for locally advanced primary rectal cancer after treatment with mFOLFOX6 plus bevacizumab, followed by preoperative chemoradiotherapy.
Nagasaki T; Akiyoshi T; Ueno M; Fukunaga Y; Nagayama S; Fujimoto Y; Konishi T; Yamaguchi T
Asian J Endosc Surg; 2014 Jan; 7(1):52-5. PubMed ID: 24450344
[TBL] [Abstract][Full Text] [Related]
16. [A Case of Pathological Complete Response after Neoadjuvant Chemotherapy(S-1 plus Oxaliplatin)and Laparoscopic Low Anterior Resection for Rectal Cancer].
Ichinohe D; Morohashi H; Umetsu S; Yoshida T; Wakasa Y; Odagiri T; Kimura T; Suto A; Saito T; Yoshida E; Akasaka H; Jin H; Miura T; Sakamoto Y; Hakamada K
Gan To Kagaku Ryoho; 2016 Nov; 43(12):1715-1717. PubMed ID: 28133108
[TBL] [Abstract][Full Text] [Related]
17. [Two Cases of Locally Advanced Lower Rectal Cancer with Pathological Complete Response after Cetuximab plus SOX as Neoadjuvant Chemotherapy].
Tokuhara K; Satake R; Ueyama Y; Yamamichi K; Sekimoto M
Gan To Kagaku Ryoho; 2021 Nov; 48(11):1405-1407. PubMed ID: 34795136
[TBL] [Abstract][Full Text] [Related]
18. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
[No Abstract] [Full Text] [Related]
19. [A case of advanced rectal cancer treated effectively with intersphincteric resection and preoperative chemotherapy].
Kimura A; Nishikawa S; Yachi T; Ito Y; Kudo Y; Kubo N; Tokura T; Umehara Y; Kurushima M; Takahashi K; Morita T
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2201-3. PubMed ID: 23268023
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of modified OPTIMOX1 plus bevacizumab as the neoadjuvant therapy for highly advanced rectal cancers].
Hirano A; Koda K; Suzuki M; Yamazaki M; Tezuka T; Kosugi C; Imai K; Nakagawa R; Adachi K; Shiragami R; Yasuda H
Gan To Kagaku Ryoho; 2012 Jul; 39(7):1087-91. PubMed ID: 22790044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
